WO2008005705A3 - Metal-containing formulations and methods of use - Google Patents

Metal-containing formulations and methods of use Download PDF

Info

Publication number
WO2008005705A3
WO2008005705A3 PCT/US2007/071867 US2007071867W WO2008005705A3 WO 2008005705 A3 WO2008005705 A3 WO 2008005705A3 US 2007071867 W US2007071867 W US 2007071867W WO 2008005705 A3 WO2008005705 A3 WO 2008005705A3
Authority
WO
WIPO (PCT)
Prior art keywords
metal
methods
containing formulations
formulations
preparation
Prior art date
Application number
PCT/US2007/071867
Other languages
French (fr)
Other versions
WO2008005705A2 (en
Inventor
Wen Gang Chen
Khailash Bhol
Jeffrey B Lyczak
Paul Schechter
Original Assignee
Nucryst Pharm Corp
Wen Gang Chen
Khailash Bhol
Jeffrey B Lyczak
Paul Schechter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucryst Pharm Corp, Wen Gang Chen, Khailash Bhol, Jeffrey B Lyczak, Paul Schechter filed Critical Nucryst Pharm Corp
Priority to AU2007269440A priority Critical patent/AU2007269440A1/en
Priority to CA002656332A priority patent/CA2656332A1/en
Priority to EP07784515A priority patent/EP2043611A2/en
Publication of WO2008005705A2 publication Critical patent/WO2008005705A2/en
Publication of WO2008005705A3 publication Critical patent/WO2008005705A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Metal-containing materials, as well as their preparation, formulations, and use are disclosed.
PCT/US2007/071867 2006-06-30 2007-06-22 Metal-containing formulations and methods of use WO2008005705A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2007269440A AU2007269440A1 (en) 2006-06-30 2007-06-22 Metal-containing formulations and methods of use
CA002656332A CA2656332A1 (en) 2006-06-30 2007-06-22 Metal-containing formulations and methods of use
EP07784515A EP2043611A2 (en) 2006-06-30 2007-06-22 Metal-containing formulations and methods of use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81805306P 2006-06-30 2006-06-30
US60/818,053 2006-06-30
US84194006P 2006-09-01 2006-09-01
US60/841,940 2006-09-01

Publications (2)

Publication Number Publication Date
WO2008005705A2 WO2008005705A2 (en) 2008-01-10
WO2008005705A3 true WO2008005705A3 (en) 2008-06-19

Family

ID=38895307

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/071867 WO2008005705A2 (en) 2006-06-30 2007-06-22 Metal-containing formulations and methods of use

Country Status (5)

Country Link
US (4) US20080014278A1 (en)
EP (1) EP2043611A2 (en)
AU (1) AU2007269440A1 (en)
CA (1) CA2656332A1 (en)
WO (1) WO2008005705A2 (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7654728B2 (en) * 1997-10-24 2010-02-02 Revalesio Corporation System and method for therapeutic application of dissolved oxygen
US6702949B2 (en) 1997-10-24 2004-03-09 Microdiffusion, Inc. Diffuser/emulsifier for aquaculture applications
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US7480530B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US20060013862A1 (en) * 2004-07-19 2006-01-19 Held Jerry M Onychomycosis: a new process for cure
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US8597689B2 (en) 2006-10-25 2013-12-03 Revalesio Corporation Methods of wound care and treatment
US8609148B2 (en) * 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8784897B2 (en) * 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US7832920B2 (en) 2006-10-25 2010-11-16 Revalesio Corporation Mixing device for creating an output mixture by mixing a first material and a second material
EP2083876A4 (en) * 2006-10-25 2012-09-19 Revalesio Corp Methods of wound care and treatment
EP2120561A4 (en) * 2007-02-19 2012-11-21 Plurogen Therapeutics Inc Compositions for treating biofilms and methods for using same
BRPI0811530B1 (en) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composition comprising inducer (s) of physiological response to decanoic acid dispersion, surface, solution, ex vivo method of treating or inhibiting the formation of a biofilm on a surface
EP2185271B1 (en) * 2007-08-25 2016-10-12 De Montfort University Antimicrobial agent and/or catalyst for chemical reactions
JP2010540542A (en) * 2007-09-28 2010-12-24 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド Power generation particles and their use
US20100303917A1 (en) * 2007-10-25 2010-12-02 Revalesio Corporation Compositions and methods for treating cystic fibrosis
US9745567B2 (en) * 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US20100029764A1 (en) * 2007-10-25 2010-02-04 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US20090227018A1 (en) * 2007-10-25 2009-09-10 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US20100009008A1 (en) * 2007-10-25 2010-01-14 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US20090263495A1 (en) * 2007-10-25 2009-10-22 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US20100303918A1 (en) * 2007-10-25 2010-12-02 Revalesio Corporation Compositions and methods for treating asthma and other lung disorders
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US20100015235A1 (en) * 2008-04-28 2010-01-21 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US10125359B2 (en) * 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof
US7998498B2 (en) * 2008-01-22 2011-08-16 Michael Szycher Antimicrobial material and method for making the same
US8367094B2 (en) 2008-01-22 2013-02-05 Michael Szycher Antimicrobial material and method for making the same
CA2723215A1 (en) * 2008-05-01 2009-11-05 Revalesio Corporation Compositions and methods for treating digestive disorders
US8150525B2 (en) * 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
US20100082088A1 (en) * 2008-08-27 2010-04-01 Ali Fassih Treatment of sweating and hyperhydrosis
US20100098659A1 (en) * 2008-10-22 2010-04-22 Revalesio Corporation Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions
BRPI0920430A2 (en) * 2008-10-22 2019-09-24 Revalesio Corp compositions and methods for treating matrix metalloproteinase 9 (mmp9) mediated conditions
WO2010057214A2 (en) * 2008-11-17 2010-05-20 Wayne State University Nanoparticles and porous particles and methods of making the same
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
CN101551926B (en) 2009-05-21 2011-09-14 广州广电运通金融电子股份有限公司 Extraneous matter detecting device of card reader and card reader jack
GB2487438B8 (en) * 2011-01-24 2014-08-06 Aidance Skincare & Topical Solutions Llc Stable silver oxide formulations
GB2472126B (en) * 2009-07-21 2011-08-03 Aidance Skincare & Topical Solutions Llc Topical Formulations Containing Silver (II) Oxide and Zinc Oxide
GB2487700A (en) 2009-11-06 2012-08-01 Aidance Skincare & Topical Solutions Llc Improved silver oxide formulations
FR2952306B1 (en) * 2009-11-09 2012-03-30 Creaspine AQUEOUS COMPOSITION FOR THE TREATMENT OF LASER FIBROUS CONJUNCTIVE TISSUE REPAIR
AU2010319733B2 (en) 2009-11-13 2014-08-07 Johnson & Johnson Consumer Companies, Inc. Galvanic skin treatment device
DE202009016573U1 (en) * 2009-12-08 2010-03-04 Schermuly, Helmut Dermal, antimicrobial foot cream
KR20110091461A (en) * 2010-02-05 2011-08-11 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 Lip compositions comprising galvanic particulates
US20110212042A1 (en) * 2010-03-01 2011-09-01 Prithwiraj Maitra Skin care composition having desirable bulk color
US20110236491A1 (en) * 2010-03-25 2011-09-29 Jeannette Chantalat Topical anti-inflammatory composition
KR20130114581A (en) 2010-05-07 2013-10-18 레발레시오 코퍼레이션 Compositions and methods for enhancing physiological performance and recovery time
EP2603202A4 (en) 2010-08-12 2016-06-01 Revalesio Corp Compositions and methods for treatment of taupathy
US10272108B2 (en) * 2011-05-05 2019-04-30 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
FR2979534B1 (en) * 2011-09-06 2013-12-27 Protip NEW INTRALARYNGEE PROSTHESIS
FR2983060B1 (en) 2011-11-30 2013-12-06 Protip MEDICAL SUPPORT DEVICE FOR IMPLANT OR PROSTHESIS
US20130344120A1 (en) * 2012-06-21 2013-12-26 Douglas Craig Scott Mouth Rinse Emulsions
US10111904B2 (en) * 2013-01-09 2018-10-30 Berlock Aps Micron-sized gold, kit comprising said gold and its use as a non-toxic immune suppressor
FR3009951B1 (en) 2013-09-05 2017-01-20 Protip INTRA-LARYNGEAL PROSTHESIS
EP3190893B1 (en) * 2014-09-12 2021-05-12 K10 Technologies, Inc. Compositions and methods for treating and preventing bacterial infections
WO2018121946A1 (en) 2016-12-27 2018-07-05 Unilever N.V. An antimicrobial composition
WO2018121933A1 (en) 2016-12-27 2018-07-05 Unilever N.V. An antimicrobial composition
MX2020001923A (en) 2017-08-25 2020-03-24 Unilever Ip Holdings B V An antimicrobial composition.
WO2019038049A1 (en) 2017-08-25 2019-02-28 Unilever N.V. An antimicrobial composition
CN111295190A (en) 2017-10-30 2020-06-16 荷兰联合利华有限公司 Use of nicotinamide for microbiome balance
CZ2017817A3 (en) * 2017-12-19 2018-11-21 Adam LuÄŤanĂ­k A fireproof water jacket
KR20200118426A (en) 2018-01-05 2020-10-15 더 유니버시티 오브 유타 리서치 파운데이션 Treatment of myopia progression
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN108998499A (en) * 2018-06-05 2018-12-14 上海海洋大学 A kind of method of Escherichia coli Antibiotic Resistance in quick measurement biofilm
CN113242751B (en) 2018-12-18 2023-09-19 联合利华知识产权控股有限公司 Antimicrobial compositions
EP4255378A1 (en) 2020-12-02 2023-10-11 Unilever IP Holdings B.V. Topical sanitising composition comprising minimal amounts of an anitmicrobial lipid

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002059A1 (en) * 2000-06-30 2002-01-10 Medicis Pharmaceuticals Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
WO2002009729A2 (en) * 2000-07-27 2002-02-07 Nucryst Pharmaceuticals Corp. Treatment of hyperproliferative skin disorders and diseases
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
WO2005074949A1 (en) * 2004-02-02 2005-08-18 Nucryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases with antimicrobial metal compositions
WO2006105362A2 (en) * 2005-03-29 2006-10-05 Nucryst Pharmaceuticals Corp. Biocompatible articles and related methods

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093186B1 (en) * 1982-05-03 1986-07-09 Richardson Vicks Limited Pharmaceutical preparation for the topical treatment of acne
US4828832A (en) * 1983-09-07 1989-05-09 Laboratorios Biochemie De Mexico Method of manufacturing a composition for treating skin lesions
GB8421706D0 (en) * 1984-08-28 1984-10-03 Pharmaceutical Holdings Ltd Pharmaceutical preparations
US5122418A (en) * 1985-12-09 1992-06-16 Shiseido Company Ltd. Composite powder and production process
US4847049A (en) * 1985-12-18 1989-07-11 Vitaphore Corporation Method of forming chelated collagen having bactericidal properties
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
US5143717A (en) * 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
US4908355A (en) * 1989-01-09 1990-03-13 Dow Corning Corporation Skin treatment method
US4980172A (en) * 1989-05-12 1990-12-25 Fey Michael S Anti-smoking oral composition
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
US5374432A (en) * 1989-07-28 1994-12-20 The Trustees Of Columbia University Of The City Of New York Topical anti-infective ointment containing silver or silver salts and antibiotics
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
FR2677544B1 (en) * 1991-06-14 1993-09-24 Oreal COSMETIC COMPOSITION CONTAINING A MIXTURE OF NANOPIGMENTS OF METAL OXIDES AND MELANIC PIGMENTS.
US5681575A (en) * 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices
GEP20002074B (en) * 1992-05-19 2000-05-10 Westaim Tech Inc Ca Modified Material and Method for its Production
US5848995A (en) * 1993-04-09 1998-12-15 Walder; Anthony J. Anti-infective medical article and method for its preparation
US5811463A (en) * 1993-10-06 1998-09-22 University Of British Columbia Compositions and method for relaxing smooth muscles
EP0727427A4 (en) * 1993-11-05 1997-10-15 Meiji Milk Prod Co Ltd Antibacterial, antifungal and antiviral agent
US5454886A (en) * 1993-11-18 1995-10-03 Westaim Technologies Inc. Process of activating anti-microbial materials
US5817325A (en) * 1996-10-28 1998-10-06 Biopolymerix, Inc. Contact-killing antimicrobial devices
GB9424562D0 (en) * 1994-12-06 1995-01-25 Giltech Ltd Product
US5589177A (en) * 1994-12-06 1996-12-31 Helene Curtis, Inc. Rinse-off water-in-oil-in-water compositions
WO1996040171A1 (en) * 1995-06-07 1996-12-19 Neuwirth Robert S Intrauterine chemical necrosing method and composition
CA2225808C (en) * 1995-06-30 2002-12-17 Christopher C. Capelli Silver-based pharmaceutical compositions
DE69728678T2 (en) * 1996-07-11 2005-04-21 Coloplast As HYDROCOLLOID-WOUND GEL
DE19640365A1 (en) * 1996-09-30 1998-04-02 Basf Ag Polymer-hydrogen peroxide complexes
US7625420B1 (en) * 1997-02-24 2009-12-01 Cabot Corporation Copper powders methods for producing powders and devices fabricated from same
US6333093B1 (en) * 1997-03-17 2001-12-25 Westaim Biomedical Corp. Anti-microbial coatings having indicator properties and wound dressings
US6071543A (en) * 1997-06-02 2000-06-06 Cellegy Pharmaceuticals, Inc. Pyridine-thiols reverse mucocutaneous aging
KR20010013377A (en) * 1997-06-04 2001-02-26 데이비드 엠 모이어 Mild, leave-on antimicrobial compositions
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6454754B1 (en) * 1998-10-29 2002-09-24 Steven R. Frank Respiratory infection treatment device
BR9915174A (en) * 1998-11-09 2001-11-06 Ira Jay Newman Ionic silver complex
US6258385B1 (en) * 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
EP1066825A1 (en) * 1999-06-17 2001-01-10 The Procter & Gamble Company An anti-microbial body care product
JP2001151681A (en) * 1999-11-24 2001-06-05 Lintec Corp Prophylactic and/or therapeutic agent for systema digestorium disease
US6224898B1 (en) * 2000-03-23 2001-05-01 The United States Of America As Represented By The Secretary Of The Army Antimicrobial dendrimer nanocomposites and a method of treating wounds
US20030170314A1 (en) * 2000-07-27 2003-09-11 Burrell Robert E. Compositions of metal-containing compounds
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US7008647B2 (en) * 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US7427416B2 (en) * 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials
ATE322274T1 (en) * 2001-04-23 2006-04-15 Nucryst Pharm Corp MEDICINAL PRODUCTS OR PLASTERS CONTAINING A METAL SUCH AS SILVER GOLD, PLATINUM OR PALLADIUM AS AN ANTIMICROBIAL ACTIVE AND THEIR USE IN THE TREATMENT OF SKIN INFLAMMATION
JP3863391B2 (en) * 2001-06-13 2006-12-27 Ｎｅｃエレクトロニクス株式会社 Semiconductor device
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
US20040009964A1 (en) * 2002-03-27 2004-01-15 Biointerface Technologies, Inc. Compositions and methods for the treatment of matrix metalloproteinase-related diseases
US6899903B2 (en) * 2002-06-25 2005-05-31 Patrick Quillin Composition for cleansing the sinuses
AU2003286575A1 (en) * 2002-10-22 2004-05-13 Nucryst Pharmaceuticals Corp. Prophylactic treatment methods
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002059A1 (en) * 2000-06-30 2002-01-10 Medicis Pharmaceuticals Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
WO2002009729A2 (en) * 2000-07-27 2002-02-07 Nucryst Pharmaceuticals Corp. Treatment of hyperproliferative skin disorders and diseases
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
WO2005074949A1 (en) * 2004-02-02 2005-08-18 Nucryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases with antimicrobial metal compositions
WO2006105362A2 (en) * 2005-03-29 2006-10-05 Nucryst Pharmaceuticals Corp. Biocompatible articles and related methods

Also Published As

Publication number Publication date
AU2007269440A1 (en) 2008-01-10
US20080014247A1 (en) 2008-01-17
US20080044491A1 (en) 2008-02-21
WO2008005705A2 (en) 2008-01-10
US20080050452A1 (en) 2008-02-28
EP2043611A2 (en) 2009-04-08
US20080014278A1 (en) 2008-01-17
CA2656332A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
WO2008005705A3 (en) Metal-containing formulations and methods of use
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
IL200407A0 (en) Stable digestive enzyme compositions, methods of producing the same and uses thereof
WO2008121767A3 (en) Stitched polypeptides
EP3284772B8 (en) Thioethers, methods for their preparation, and compositions including such thioethers
WO2007144779A3 (en) Compositions comprising porphyra and methods of making and using thereof
WO2008049116A3 (en) Substituted indoles
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
WO2007121131A3 (en) Medical devices including shape memory materials
WO2008052187A3 (en) Antibodies and immunoconjugates and uses therefor
WO2008100805A3 (en) Anti-robo4 antibodies and uses therefor
ZA200901132B (en) Human GLP-1 mimetibodies, compositions, methods and uses
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2009052125A9 (en) Human anti-amyloid antibodies, compositions, methods and uses
WO2008002893A8 (en) Anti-amyloid antibodies, compositions, methods and uses
WO2008027600A3 (en) Imatinib compositions
GB0601143D0 (en) Uses, methods and compositions
WO2009014781A3 (en) Metal-containing materials for treatment of bacterial conditions
WO2008017079A3 (en) Dyes and precursors and conjugates thereof
EP1979269A4 (en) Chlorite formulations, and methods of preparation and use thereof
GB0706077D0 (en) Methods, Compositions and uses thereof
PL2155688T3 (en) Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them.
WO2007067784A3 (en) Liposomal compositions
WO2010025370A3 (en) Preparation of ranolazine
EP2074258A4 (en) Fiberboards, uses and methods of preparation thereof

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2656332

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007784515

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007269440

Country of ref document: AU

NENP Non-entry into the national phase

Ref country code: RU

ENP Entry into the national phase

Ref document number: 2007269440

Country of ref document: AU

Date of ref document: 20070622

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07784515

Country of ref document: EP

Kind code of ref document: A2